Summary: An elevated erythrocyte sedimentation rate is generally regarded as an unspeciflc and mostly pathological indicator of inflammation or tumour. However, we have determined the concentrations of plasma/serum proteins that influence the erythrocyte sedimentation rate in numerous samples from several groups of patients with different diseases, including 2 forms of cancer. Equations have been developed by which the l h value of erythrocyte sedimentation rate can be expressed as the sum of disease-specific coefficients for each protein multiplied by the measured concentrations of the respective proteins. These equations are shown to be disease-specific with 64 -93% probability. Such equations may thus form the basis for differential diagnosis.
Introduction
Since the fundamental work of Fähraeus (1) and Westergren (2) , an elevated erythrocyte sedimentation rate has been looked upon as an unspecific and mostly pathological indicator, which is often elevated on both acute and chronic inflammation states, various types of cancer and during the last months of pregnancy. Even in the mentioned studies, it was recognized that an elevated erythrocyte sedimentation rate is usually accompanied by an increased fibrinogen concentration. We showed in 1966 (3) that elevated concentrations of several plasma proteins, such as coeruloplasmin, haptoglobin or o^-macroglobulin, can also cause an elevated erythrocyte sedimentation rate. We named these proteins agglomerins (4) .
Evidence for some disease-related specificity of the erythrocyte sedimentation rate was first mentioned in This research was supported in part by Texmana AG, CH-6052 Hergiswil, Switzerland. 1975 (5) . We observed that irrespective of age, sex or duration of diseases in different groups of diseases with elevated erythrocyte sedimentation rate, the values of the correlation coefficients for the concentration of different agglomerins had a disease specific order. This observation is supported by the finding that the ratios between the concentrations of the investigated plasma proteins remain fairly constant during the course of a heart infarct or other diseases (5) . Also, the observation that an elevated erythrocyte sedimentation rate is decreased to different extents by prednisolone, depending on the accompanying disease, favours the assumption that the erythrocyte sedimentation rate mechanism is specific (6) . This prompted the following model study on patient groups with different diseases, aimed at the development of a procedure for differential diagnosis, based on analysis of the relationship between elevated erythrocyte sedimentation rate and the concentrations of certain plasma proteins.
Materials and Methods
The study consists of three parts with respectively four (part I) and two (part II and III) groups of patients, each group consisting of patients with an identical disease. No selection for the patient age and the stage of their diseases was made.
Serum and citrated blood (1+4) were obtained from the patients and 5 ml of the blood was centrifuged (10 min, 3000 g). To normalize the concentrations of erythrocytes, a mixture of 1 ml of the supernatant plasma and 0.5 ml packed erythrocytes was used. The further procedure for determining the l h erythrocyte sedimentation rate was performed according to the rules for standardization of the erythrocyte sedimentation rate (7) . The correlation coefficient r of duplicate measurements of the l h value was 0.96. Serum and plasma samples were stored at -70 °C before analysis.
In the plasma the concentration of flbrinogen was determined by immunodiffusion (NOR-Partigen plates Behring-Werke D-3550 Marburg/Lahn, Germany). In sera, the concentrations of the following serum proteins were measured by immunodifTusion (Partigenplates; Behringwerke, D-3550 Marburg/Lahn, Germany): C-reactive protein, immunoglobulin A, immunoglobulin G and immunoglobulin M. In parts I and III of the study the following serum proteins were further assayed by the method of Clarke-Freeman (8): albumin, acid-a t -glycoprotein, a r antitrypsin, oci-lipoprotein, a 2 -macroglobulin, complement C 3 , coeruloplasmin, haptoglobin, prealbumin, transferrin.
The mean imprecision of the protein concentration values measured by the Clarke-Freeman method was CV < ± 5.5%. In part II zone immunoelectrophoresis assay (ZIA) (9) was used instead of the method of Clarke-Freeman for measurement of the respective protein concentrations. The imprecision of zone immunoelectrophoresis assay is CV ±3% (10) .
By measuring the erythrocyte sedimentation rate and the plasma/serum protein concentrations of every patient, we obtained one block of values for each group of patients.
Patients
Patients came from the University clinics of Munich and Lü-beck (Germany) with clinically asserted diagnoses.
Part I
Four groups of patients were investigated with the following diseases: erysipela, malignant melanoma, multiple sclerosis and carcinoma of the uterus. These 4 groups were chosen as examples of an acute inflammation, a very acute tumour, a chronic inflammation and a tumour with a more protracted course. All erysipela patients had been hospitalized due to the severity of their disease. Table 1 shows the mean age and the sex distribution as well as the mean duration time of acute multiple sclerosis patients and of the other groups when the blood was taken. The melanoma patients were hospitalized because of known or suspected metastases. The time since operation of the primary tumour is indicated in table 1. The diagnosis of patients with multiple sclerosis was ensured by the typical multiple sclerosis liquor inflammation state and computer NMR tomography (11) . The blood of the patients with uterus carcinoma had been taken before the operation of the tumour. Calculation (12) At the beginning of the study we calculated a simple linear regression function between erythrocyte sedimentation rate and the concentration for each single protein, using all the individual values from every group. After that, the difference between the calibration (regression line) value and the measured value was determined for each plasma protein concentration of every patient. The disease with the greatest number of minimal differences was taken as the diagnosis. However, by this procedure the number of errors was considerably greater compared with the multiple regression method described below.
By the method of stepwise linear regression a certain T-value of significance was stated. Then in each group the regression equation with all parameters (plasma/serum concentration against erythrocyte sedimentation rate) was calculated, and all parameters transgressing the chosen T-value was eliminated stepwise.
The basis of these calculations was each block of values from patients with the different diseases. The plasma/serum protein concentration of each patient was expressed in percent of the assigned normal values of human serum (Behring-Werke, D-3550 Marburg/Lahn, Germany). In the first part of the study the plasma/serum values were normalized so that the values equalling the assigned normal values became zero. Higher values are given in percent of the assigned values. In the two other parts of the study, the normal values were assigned a value of 100. For each group this procedure led to a vector of coefficients for every parameter of the equation. The coefficients of the equations were obtained by using the sum of squares of deviations to obtain a minimum when using all measured concentrations of plasma/serum proteins of all patients of one block.
We then compared again in every part of the study the calculated erythrocyte sedimentation rate of each patient with the measured erythrocyte sedimentation rate. The value closest to one of the values of an equation was taken for the probable diagnosis.
For these calculations we developed a program in Pascal. To test the quality of the regression we used three values: the Ttest (the significance of impact of a certain coefficient of an equation) the F-test (the probability of the independence of erythrocyte sedimentation rate (ESR) on certain parameters of the model) and the Revalue (the multiple correlation coefficient): Σ(Ε8Κι -ESR) Cj to c t5 are fixed coefficients, and the three letters represent the concentrations of the plasma/serum proteins albumin, otr antitrypsin, coeruloplasmin, transferrin in percentage of the normal values.
We applied every equation to the concentrations of all the plasma/serum proteins which had been estimated in each individual in each block. Moreover, within the blocks those proteins were excluded which had no or almost no influence on the variability of the erythrocyte sedimentation rate values expressed by R 2 .
Results
In part 1,40 patients with erysipela, 13 with malignant melanoma, 15 with multiple sclerosis and 22 with uterine carcinoma were studied. and this in fact proves to be correct (tab. 3). The table shows the probability of the correct or false diagnosis for the total of the 90 investigated patients: within the four blocks the correct diagnosis varies between 64 and 87%. Table 4 contains the two equations of part II of the study. Again there are distinct differences in the analogous coefficients of single plasma/serum protein concentrations. Accordingly the best fits for a differential diagnosis within these two blocks amount to 79 and 89% for multiple sclerosis and uterine carcinoma, respectively (tab. 5). The first two parts were merely done to investigate the principle, i.e. the possibility of differential diagnosis by analysis of plasma protein concentrations and erythrocyte sedimentation rate. The result of the third part is especially promising. Here we compared multiple sclerosis patients and patients with different inflammatory diseases of the nervous system except multiple sclerosis. The two equations differ distinctly (tab. 6). The probability for correct diagnosis of the two disease groups was 93% (tab. 7).
Discussion
Our investigations are based on the following considerations. Former results (5) indicated the possible existence of functional and disease-specific connections between the erythrocyte sedimentation rate as a dependent variable and the concentrations of several plasma proteins as independent variables. These variables together would form a multidimensional space of parameters inside of which every patient would be characterized by a certain point. In the ideal case of measurements without experimental error, and with no parameters other than the measured ones influencing the erythrocyte sedimentation rate, it should be possible to derive equations of curves (in the simplest case straight lines) which contain all data points. And if the connections between the concentrations of plasma proteins and the erythrocyte sedimentation rate were sufficiently different for different diseases, one should be able to develop programs for differential diagnosis between diseases with elevated erythrocyte sedimentation rate: the greater the differences between the specific equations of two diseases the better the diagnostic efficiency.
In practice the data points will not lie on a curve, but rather be scattered around the expected curve, due to the experimental error of the measurements and other non-measured variables influencing the erythrocyte sedimentation rate.
The characteristic equation for a certain disease would be best derived by the method of least squares (multiple linear or non-linear) regression. For all data points of patients with a certain disease, the expected value of the distance from this curve is zero. However, data points of patients with other diseases would be expected to have distances more or less different from zero (depending on the differences of the two respective equations).
For proving such disease-specific equations one would have to measure the above mentioned variables on a sufficiently large group of patients with the disease, so that the addition of further patients would hardly change the equation derived from the data set. Furthermore, the division of a group of patients into two subgroups should yield two similar equations.
The procedure of handling of the disease-specific equations may be explained by an example. Suppose a malignant melanoma patient had a 1 h-erythrocyte sedimentation rate of 50 mm. The concentrations of his plasma/serum proteins are inserted into the malignant malinoma formula of In this study we tested two methods for measuring the protein concentrations and partly also different groups of proteins to find optimum conditions. However, none of these variations improved the results in any of the three parts.
The multiple sclerosis group values of part I and III are identical as they stem from the same patients. However, the corresponding two equations are partly different. The reason for this is that the proteins used in the equations of part I and III are only partly identical. These partial differences in the two equations show the importance of the choice of the measured proteins and the interdependence of the coefficients. The equation of the multiple sclerosis group of part II is based on the measurement of the protein concentrations by zone immunoelectrophoresis assay (ZIA), while those in part I and III are based on the Clarke-Freeman method. This may also account for its difference from to the multiple sclerosis-equations in part I and II.
From the result of part III two consequences follow: a) even if only one organ system is involved, specific plasma/serum protein profiles may indicate distinct diseases and b) different unspecific inflammatory diseases of the nervous system may be combined into one group in our analysis. All previous investigations of the possible diseasespecific influence of the plasma/serum protein profile on the erythrocyte sedimentation rate have failed to produce positive results (see, e. g. 1. c. (13)). The reason for this is obviously that the correlations between protein concentrations and the erythrocyte sedimentation rate are weak. From our work, however, it can be concluded that the pattern of different plasma/ serum proteins to which the erythrocyte surface is exposed, i. e. the distribution of influences of the single plasmaproteins in dependence of the whole of the proteins seems to be more or less disease-specific and independent of the values of the erythrocyte sedimentation rate.
The Jesuits of the present study are challanging, but they do not definitely prove our hypothesis, because a) the number of cases studied in some classes of disease was not quite sufficient, and b) there were problems with the reproducibility of the protein quantification.
For the practical clinical application of sedimentation equations it is necessary to obtain sedimentation equations with general validity a) by enlarging the number of measured plasma proteins and the number of patients of every disease group, b) by using a plasma/serum concentration estimation method with high reproducibility and clinical practicability, c) by selecting the best fitting proteins for the correlation calculations, and d) by determining the equations of further diseases with elevated erythrocyte sedimentation rate. Obviously, with improvement, the results of calculations should be improved accordingly.
Beside this possibility of differential diagnosis, our findings demonstrate that the feed-back mechanisms of the concentrations of plasma proteins are interdependent, and that this interdependency is diseasespecific. This may help in understanding the defence reaction of diseases with an elevated erythrocyte sedimentation rate.
